azacitidine and Neuroendocrine Tumors

azacitidine has been researched along with Neuroendocrine Tumors in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Aboagye, EO; Archibald, S; Beaumont, J; Beckley, A; Braga, M; Butt, S; Cawthorne, C; Evans, JS; Karali, CS; Masrour, N; Mauri, F; Sharma, R1
Acharya, NK; Badach, J; Emery, R; Hong, YK; Jelinek, J; Joneja, U; Lin, A; Madzo, J; Platoff, R; Sandilos, G; Williamson, J; Zhang, P; Zhu, C; Zilberman, B1
Adel Fahmideh, M; Fotouhi, O; Hashemi, J; Höög, A; Kjellman, M; Larsson, C; Sulaiman, L; Zedenius, J1
Evers, BM; Kim, JT; Lee, EY; Li, J; Song, J; Townsend, CM; Weiss, HL1

Other Studies

4 other study(ies) available for azacitidine and Neuroendocrine Tumors

ArticleYear
Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy.
    European journal of cancer (Oxford, England : 1990), 2022, Volume: 176

    Topics: Azacitidine; Epigenesis, Genetic; Humans; Neuroendocrine Tumors; Octreotide; Receptors, Somatostatin; Somatostatin

2022
Novel treatment strategy of targeting epigenetic dysregulation in pancreatic neuroendocrine tumors.
    Surgery, 2023, Volume: 173, Issue:4

    Topics: Animals; Azacitidine; DNA; Epigenesis, Genetic; Humans; Methyltransferases; Mice; Neuroendocrine Tumors; Pancreatic Neoplasms

2023
Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
    Epigenetics, 2014, Volume: 9, Issue:7

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Chromosomes, Human, Pair 18; Cluster Analysis; DNA (Cytosine-5-)-Methyltransferases; DNA Copy Number Variations; DNA Methylation; Female; Genome, Human; Humans; Intestinal Neoplasms; Intestine, Small; Long Interspersed Nucleotide Elements; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Promoter Regions, Genetic; RNA, Messenger; Survival Rate; Tumor Suppressor Proteins

2014
Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.
    Oncotarget, 2015, Sep-29, Volume: 6, Issue:29

    Topics: Azacitidine; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Decitabine; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunohistochemistry; Lentivirus; Neoplasm Invasiveness; Neuroendocrine Tumors; Promoter Regions, Genetic; Receptors, Neurotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering

2015